2 DAYS LEFT - Lock in a permanent 25% discount off all our Premium Trading Services & Tools https://www.clickcapital.io/ (Use code JUL25)
9 extracted signals · 9 resolved · 0 still active
Click CapitalIndependent analyst profile- Source published
- 29 Jul 2025, 23:26 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis suggests a potential short-term market top. VIX is currently at 15.97, with a projected increase to 25, but a fail if price below 14.00. SPX is at 6370.87, targeting a decline to 5850, invalidating if it exceeds 6500. DXY1 is at 98.69, targeting 101, with analysis failing if price is below 97. The speaker projects CL1 to target 78, from 69.21, but fails at 67. PayPal, currently at 71.45, is expected to reach 100, with fail bound at 67. NVDA target is 145 if actual price break 190, actual price 175. 51. SPOT has a downward target of 507.84 with a current price of 620.01, analysis invalidation if the price exceeds 625. Novo Nordisk at 53.06, targeting 32.00, with fail price at 60. A decline from 90.84 to 76 is projected for UPS, but analysis ineffective after a price of 95. Apple targeting 185 from 211.27, invalidation occurs if price exceed 220.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
9 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Click Capital
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.